|
1
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inglehart RC, Scanlon CS and Silva NJ:
Reviewing and reconsidering invasion assays in head and neck
cancer. Oral Oncol. 12:1137–1143. 2014. View Article : Google Scholar
|
|
4
|
Shukla GC, Singh J and Barik S: MicroRNAs:
Processing, maturation, target recognition and regulatory
functions. Mol Cellular Pharmacol. 3:83–92. 2011.
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hui ABY, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar
|
|
7
|
Liu X, Bi L, Wang Q, Wen M, Li C, Ren Y,
Jiao Q, Mao JH, Wang C, Wei G and Wang Y: MiR-1204 targets VDR to
promotes epithelial-mesenchymal transition and metastasis in breast
cancer. Oncogene. 37:3426–3439. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiiba M, Uzawa K and Tanzawa H: MicroRNAs
in head and neck squamous cell carcinoma (HNSCC) and oral squamous
cell carcinoma (OSCC). Cancers (Basel). 2:653–669. 2010. View Article : Google Scholar
|
|
9
|
Li Y, He Q, Wen X, Hong X, Yang X, Tang X,
Zhang P, Lei Y, Sun Y, Zhang J, et al: EZH2-DNMT1-mediated
epigenetic silencing of miR-142-3p promotes metastasis through
targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ.
26:1089–1106. 2019. View Article : Google Scholar :
|
|
10
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong Y, Zheng Y, Wang C, Ding X, Du Y, Liu
L, Zhang W, Zhang W, Zhong Y, Wu Y and Song X: MiR-876-5p modulates
head and neck squamous cell carcinoma metastasis and invasion by
targeting vimentin. Cancer Cell Int. 18:1212018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin
YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, et al:
Downregulated miR329 and miR410 promote the proliferation and
invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Cancer Res. 74:7560–7572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Carvalho AC, Scapulatempo-Neto C, Maia
DC, Evangelista AF, Morini MA, Carvalho AL and Vettore AL: Accuracy
of microRNAs as markers for the detection of neck lymph node
metastases in patients with head and neck squamous cell carcinoma.
BMC Med. 13:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nadal E, Zhong J, Lin J, Reddy RM, Ramnath
N, Orringer MB, Chang AC, Beer DG and Chen G: A MicroRNA cluster at
14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res.
20:3107–3117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Xu G, Liu G, Ye Y, Zhang C, Fan
C, Wang H, Cai H, Xiao R, Huang Z and Luo Q: MiR-411-5p inhibits
proliferation and metastasis of breast cancer cell via targeting
GRB2. Biochem Bioph Res Commun. 476:607–613. 2016. View Article : Google Scholar
|
|
16
|
Zhang X, Zhang M, Cheng J, Lv Z, Wang F
and Cai Z: MiR-411 functions as a tumor suppressor in renal cell
cancer. Int J Biol Markers. 32:e454–e460. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang C, Wang H, Liu X, Hu Y, Ding L,
Zhang X, Sun Q and Li Y: Oncogenic microRNA-411 promotes lung
carcinogenesis by directly targeting suppressor genes SPRY4 and
TXNIP. Oncogene. 38:1892–1904. 2019. View Article : Google Scholar :
|
|
18
|
Garcia E, Marcos-Gutierrez C, del Mar
Lorente M, Moreno JC and Vidal M: RYBP, a new repressor protein
that interacts with components of the mammalian Polycomb complex,
and with the transcription factor YY1. EMBO J. 18:3404–3418. 1999.
View Article : Google Scholar
|
|
19
|
Zhao Q, Cai W, Zhang X, Tian S, Zhang J,
Li H, Hou C, Ma X, Chen H, Huang B and Chen D: RYBP expression is
regulated by KLF4 and Sp1 and is related to hepatocellular
carcinoma prognosis. J Biol Chem. 292:2143–2158. 2017. View Article : Google Scholar :
|
|
20
|
Zhou H, Li J, Zhang Z, Ye R, Shao N,
Cheang T and Wang S: RING1 and YY1 binding protein suppresses
breast cancer growth and metastasis. Int J Oncol. 49:2442–2452.
2016. View Article : Google Scholar
|
|
21
|
Voruganti S, Xu F, Qin JJ, Guo Y, Sarkar
S, Gao M, Zheng Z, Wang MH, Zhou J, Qian B, et al: RYBP predicts
survival of patients with non-small cell lung cancer and regulates
tumor cell growth and the response to chemotherapy. Cancer Lett.
369:386–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu X, Yan M, Luo W, Liu W, Ren Y, Bei C,
Tang G, Chen R and Tan S: Expression and clinical significanceof
PcG-associated protein RYBP in hepatocellular carcinoma. Oncol
Lett. 13:141–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luan PB, Jia XZ and Yao J: MiR-769-5p
functions as an oncogene by down-regulating RYBP expression in
gastric cancer. Eur Rev Med Pharmacol Sci. 24:6699–6706.
2020.PubMed/NCBI
|
|
24
|
Zhao G, Li Q, Wang A and Jiao J: YY1
regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis. J Exp
Clin Cancer Res. 34:662015. View Article : Google Scholar
|
|
25
|
Pérez Sayáns M, Chamorro Petronacci CM,
Lorenzo Pouso AI, PadíIruegas E, Blanco Carrión A, Suárez Peñaranda
JM and García García A: Comprehensive genomic review of TCGA head
and neck squamous cell carcinomas (HNSCC). J Clin Med. 8:18962019.
View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
National Research Council (US) Committee
for the Update of the Guide for the Care and use of Laboratory
Animals: Guide for the care and use of laboratory animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
28
|
Loberg RD, Bradley DA, Tomlins SA,
Chinnaiyan AM and Pienta KJ: The lethal phenotype of cancer: The
molecular basis of death due to malignancy. CA Cancer J Clin.
57:225–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu N, Yang W, Liu Y, Yan F and Yu Z:
MicroRNA-411 promoted the osteosarcoma progression by suppressing
MTSS1 expression. Environ Sci Pollutr Res Int. 25:12064–12071.
2018. View Article : Google Scholar
|
|
30
|
Zhao J, Xu J and Zhang R: MicroRNA-411
inhibits malignant biological behaviours of colorectal cancer cells
by directly targeting PIK3R3. Oncol Rep. 39:633–642. 2018.
|
|
31
|
Jin H, Sun W, Zhang Y, Yan H, Liufu H,
Wang S, Chen C, Gu J, Hua X, Zhou L, et al: MicroRNA-411
downregulation enhances tumor growth by upregulating MLLT11
expression in human bladder cancer. Mol Ther Nucleic Acids.
11:312–322. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Y, Liu T, Jin H, Yin L, Yu H and Bi J:
MiR-411 suppresses the development of bladder cancer by regulating
ZnT1. Onco Targets Ther. 11:8695–8704. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai TL, Liu YB and Li BH: MiR-411 inhibits
gastric cancer proliferation and migration through targeting SETD6.
Eur Rev Med Pharmaco. 23:3344–3350. 2019.
|
|
34
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Bio. 15:178–196. 2014. View Article : Google Scholar
|
|
36
|
Domingues CSDC, Serambeque BP, Laranjo
Cândido MS, Marto CMM, Veiga FJB, Sarmento Antunes Cruz Ribeiro AB,
Figueiras ARR, Botelho MFR and Dourado MARF: Epithelial-mesenchymal
transition and microRNAs: Challenges and future perspectives in
oral cancer. Head Neck. 40:2304–2313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin Z, Sun L, Chen W, Liu B, Wang Y, Fan
S, Li Y and Li J: MiR-639 regulates transforming growth factor
beta-induced epithelial-mesenchymal transition in human tongue
cancer cells by targeting FOXC1. Cancer Sci. 105:1288–1298. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dinglin X, Ding L, Li Q, Liu Y, Zhang J
and Yao H: RYBP inhibits progression and metastasis of lung cancer
by suppressing EGFR signaling and epithelial-mesenchymal
transition. Transl Oncol. 10:280–287. 2017. View Article : Google Scholar : PubMed/NCBI
|
